202 related articles for article (PubMed ID: 24647357)
21. Apelin Is a Negative Regulator of Angiotensin II-Mediated Adverse Myocardial Remodeling and Dysfunction.
Zhang ZZ; Wang W; Jin HY; Chen X; Cheng YW; Xu YL; Song B; Penninger JM; Oudit GY; Zhong JC
Hypertension; 2017 Dec; 70(6):1165-1175. PubMed ID: 28974565
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis.
Fu J; Huang H; Liu J; Pi R; Chen J; Liu P
Eur J Pharmacol; 2007 Jul; 568(1-3):213-21. PubMed ID: 17537428
[TBL] [Abstract][Full Text] [Related]
23. Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR.
Conde MV; Gonzalez MC; Quintana-Villamandos B; Abderrahim F; Briones AM; Condezo-Hoyos L; Regadera J; Susin C; Gomez de Diego JJ; Delgado-Baeza E; Diaz-Gil JJ; Arribas SM
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1153-65. PubMed ID: 21642499
[TBL] [Abstract][Full Text] [Related]
24. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
25. Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension.
Buzello M; Boehm C; Orth S; Fischer B; Ehmke H; Ritz E; Mall G; Amann K
Virchows Arch; 2003 Apr; 442(4):364-71. PubMed ID: 12684765
[TBL] [Abstract][Full Text] [Related]
26. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
[TBL] [Abstract][Full Text] [Related]
27. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: Possible role of silent information regulator 1.
Feng J; Li S; Chen H
Eur J Pharmacol; 2016 Nov; 791():632-639. PubMed ID: 27693799
[TBL] [Abstract][Full Text] [Related]
29. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.
Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ
J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806
[TBL] [Abstract][Full Text] [Related]
30. Caveolin-1-Autophagy Pathway Mediated Cardiomyocyte Hypertrophy Induced by Apelin-13.
Wu D; Xie F; Xiao L; Feng F; Huang S; He L; Liu M; Zhou Q; Li L; Chen L
DNA Cell Biol; 2017 Aug; 36(8):611-618. PubMed ID: 28537760
[TBL] [Abstract][Full Text] [Related]
31. Effects of Baicalin on Blood Pressure and Left Ventricular Remodeling in Rats with Renovascular Hypertension.
Dai H; Zhang X; Yang Z; Li J; Zheng J
Med Sci Monit; 2017 Jun; 23():2939-2948. PubMed ID: 28622281
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes.
HONG HJ; LIU JC; CHENG TH; CHAN P
Acta Pharmacol Sin; 2010 Dec; 31(12):1569-75. PubMed ID: 21102479
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Fang J; Xu SW; Wang P; Tang FT; Zhou SG; Gao J; Chen JW; Huang HQ; Liu PQ
Phytomedicine; 2010 Dec; 18(1):58-64. PubMed ID: 20638255
[TBL] [Abstract][Full Text] [Related]
34. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA protects against chronic intermittent hypoxia-induced myocardial injury via activating the endothelin 1 pathway.
Wang N; Chang Y; Chen L; Guo YJ; Zhao YS; Guo QH; Ji ES
Biomed Pharmacother; 2017 Nov; 95():1013-1020. PubMed ID: 28922718
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis.
Xu S; He L; Ding K; Zhang L; Xu X; Wang S; Qian X
Drug Des Devel Ther; 2020; 14():5773-5782. PubMed ID: 33408464
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
38. Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction.
Ueda S; Yamagishi S; Matsui T; Jinnouchi Y; Imaizumi T
Am J Pathol; 2011 Feb; 178(2):591-8. PubMed ID: 21281791
[TBL] [Abstract][Full Text] [Related]
39. Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts.
Briest W; Hölzl A; Rassler B; Deten A; Baba HA; Zimmer HG
Cardiovasc Res; 2003 Feb; 57(2):379-87. PubMed ID: 12566110
[TBL] [Abstract][Full Text] [Related]
40. The effect of angoroside C on pressure overload-induced ventricular remodeling in rats.
Gu WL; Chen CX; Huang XY; Gao JP
Phytomedicine; 2015 Jul; 22(7-8):705-12. PubMed ID: 26141756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
